64B18-17.003: Continuing Education Programs Not Requiring Pre-Approval from the Board
PURPOSE AND EFFECT: he Board proposes the rule amendment to remove language that provided the HIV/AIDS education course did not require pre-approval from the Board.
SUMMARY: HIV/AIDS education course will now required pre-approval from the Board.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:
The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the agency.
The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
RULEMAKING AUTHORITY: 456.013, 456.033(7), 461.005, 461.007 FS.
LAW IMPLEMENTED: 456.013(6), 456.033(1), 461.007 FS.
A HEARING WILL BE HELD AT THE DATE, TIME AND PLACE SHOWN BELOW:
DATE AND TIME:
PLACE:
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Bruce Deterding, Executive Director, Board of Podiatric Medicine, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3257.
THE FULL TEXT OF THE PROPOSED RULE IS:
64B18-17.003 Continuing Education Programs Not Requiring Pre-Approval from the Board.
(1) through (3) No change.
(4) HIV/AIDS Educational Course. A podiatric physician who attends an HIV/AIDS course that consists of education on the modes of transmission, infection control, procedures, treatment, clinical management and prevention of Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome, with emphasis on appropriate behavior and attitude change, shall be credited with one (1) hour of continuing education credit for each hour of the program up to a maximum of three (3) hours during the biennium. Such course shall also include information on current Florida law and its impact on testing, confidentiality of test results, treatment of patients, and any protocols and procedures applicable to human immunodeficiency virus counseling and testing, reporting, the offering of HIV testing to pregnant women, and partner notification issues pursuant to Sections 381.004 and 384.25, F.S. A podiatric physician who takes advantage of this provision and whose continuing education is audited must provide certification from the provider of the program which specifies the areas covered by the program and which demonstrates that the podiatric physician has attended the requisite number of hours thereof.
Rulemaking Authority 456.013, 456.033(7), 461.005, 461.007 FS. Law Implemented 456.013, 456.033(1), 461.007 FS. HistoryNew 11-24-80, Formerly 21T-17.03, Amended 10-14-86, 2-22-87, 5-16-89, 6-19-90, Formerly 21T-17.003, Amended 7-6-94, Formerly 61F12-17.003, Amended 12-19-94, 1-1-96, 6-12-96, Formerly 59Z-17.003, Amended 8-8-99, 9-20-10, .
